Due to fraudulence and misconduct in research, advances in Alzheimer’s Disease treatments have been hindered. Read More.
Other Posts
The Quiet Inequality Behind Fertility Care
Access to fertility care in Europe is far from equal. Starting a family is often shaped by laws, cost, and geography rather than personal choice alone. Legal restrictions and limited public coverage mean access depends [...]
Designing Life: The Ethics of Choosing Our Children
Polygenic embryo screening is a new IVF technology that lets parents assess embryos for genetic risk, from heart disease to, controversially, intelligence and height. While marketed as a path to healthier babies, the science is [...]
When Algorithms Stand Between Patients and Care
A new federal pilot program, the Wasteful and Inappropriate Service Reduction (WISeR) model, is putting AI in charge of Medicare prior authorizations and it's already raising concerns, including reported delays at the University of Washington [...]
When Science Crosses the Line: Lessons from Three Identical Strangers
In the 2025 BEI Winter School lecture, Dr. Ilene Wilets, an Associate Professor at the Icahn School of Medicine at Mount Sinai and Chair of its Institutional Review Board, led a discussion on Three Identical [...]
Who Gets In? Algorithms, Bias, and Clinical Trial Access
Clinical trial recruitment is often treated as a logistical hurdle. In reality, it determines who is included in research, who bears risk, and whose experiences shape medical knowledge. In this lecture from the 2025 BEI [...]
Artificial Conscience: Who is Responsible When AI Gets It Wrong?
We tend to assume that disagreement in medicine happens between people. What happens when it’s between a clinician and an algorithm? In this 2025 BEI Winter School lecture, Dr. Bryan Pilkington, an Associate Professor in [...]
